“MONITORING THE FREQUENCY OF ADVERSE EVENTS FOLLOWING VACCINATION UPTO 6-YEAR-OLD CHILDREN”, Int. Res. J. Pharm., vol. 7, no. 6, pp. 128–132, Jun. 2016, doi: 10.56802/7h2sfe36.